Explore how RPMI 1640 supports cancer and immunology research by providing essential nutrients for cell growth, metabolism, ...

Selenium in renal cell carcinoma showed context dependent redox effects, lowering reactive oxygen species in baseline ...

Impact of multimodal, multidisciplinary care on clinical outcomes in patients with breast cancer and leptomeningeal carcinomatosis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I ...

Researchers at CSH Laboratory identified an oncogenic SRSF1–AURKA–MYC circuit driving pancreatic ductal adenocarcinoma.

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

Antioxidants have long been regarded as key players in protecting cells and maintaining health, but a research team led by ...

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

Pancreatic ductal adenocarcinoma (PDAC) is both the most common and the deadliest type of pancreatic cancer. Most treatment ...